Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS about Proposed Decision for Medicare Coverage of NGS for Advanced Cancer
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Letter to Congress Concerning the FDA Technical Assistance for the Diagnostic Accuracy and Innovation Act (DAIA)
-
Group Sign-on Letter to Congress Concerning the Diagnostic Accuracy and Innovation Act (DAIA)